You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Chronic kidney disease

Dapagliflozin for treating chronic kidney disease

  • Technology appraisal guidance
  • Reference number: TA1075
  • Published:  02 July 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality impact assessment (downloadable version) (PDF 128 KB)

    Published:
    02 July 2025

Final draft guidance

  • Final draft guidance

  • Final draft guidance (PDF 112 KB)

    Published:
    30 May 2025
  • Committee papers (PDF 9.77 MB)

    Published:
    30 May 2025
  • Equality impact assessment (downloadable version) (PDF 128 KB)

    Published:
    30 May 2025

Invitation to participate

  • Final scope (PDF 275 KB)

    Published:
    17 May 2024
  • Final stakeholder list (PDF 162 KB)

    Published:
    21 May 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 145 KB)

    Published:
    21 May 2024
  • Equality impact assessment (Scoping) (PDF 140 KB)

    Published:
    21 May 2024
Back to top